180 related articles for article (PubMed ID: 25794093)
1. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.
Tan CH; Hobbs BP; Wei W; Kundra V
AJR Am J Roentgenol; 2015 Apr; 204(4):W439-48. PubMed ID: 25794093
[TBL] [Abstract][Full Text] [Related]
2. A systematic review on multiparametric MR imaging in prostate cancer detection.
Fusco R; Sansone M; Granata V; Setola SV; Petrillo A
Infect Agent Cancer; 2017; 12():57. PubMed ID: 29093748
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.
Zhang J; Li L; Zhang L; Zhe X; Tang M; Lei X; Zhang X
Front Oncol; 2024; 14():1332783. PubMed ID: 38544833
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis.
Chen Z; Zheng Y; Ji G; Liu X; Li P; Cai L; Guo Y; Yang J
Oncotarget; 2017 Sep; 8(44):77975-77989. PubMed ID: 29100440
[TBL] [Abstract][Full Text] [Related]
5. Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.
Chang YC; Ackerstaff E; Tschudi Y; Jimenez B; Foltz W; Fisher C; Lilge L; Cho H; Carlin S; Gillies RJ; Balagurunathan Y; Yechieli RL; Subhawong T; Turkbey B; Pollack A; Stoyanova R
Sci Rep; 2017 Aug; 7(1):9746. PubMed ID: 28851989
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls.
Fennessy FM; McKay RR; Beard CJ; Taplin ME; Tempany CM
Transl Oncol; 2014 Feb; 7(1):120-9. PubMed ID: 24772215
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer: top places where tumors hide on multiparametric MRI.
Rosenkrantz AB; Verma S; Turkbey B
AJR Am J Roentgenol; 2015 Apr; 204(4):W449-56. PubMed ID: 25794094
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives.
Scheenen TW; Rosenkrantz AB; Haider MA; Fütterer JJ
Invest Radiol; 2015 Sep; 50(9):594-600. PubMed ID: 25974203
[TBL] [Abstract][Full Text] [Related]
10. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
Hötker AM; Mazaheri Y; Zheng J; Moskowitz CS; Berkowitz J; Lantos JE; Pei X; Zelefsky MJ; Hricak H; Akin O
Eur Radiol; 2015 Sep; 25(9):2665-72. PubMed ID: 25820537
[TBL] [Abstract][Full Text] [Related]
12. Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.
Katelaris NC; Bolton DM; Weerakoon M; Toner L; Katelaris PM; Lawrentschuk N
Korean J Urol; 2015 May; 56(5):337-45. PubMed ID: 25964833
[TBL] [Abstract][Full Text] [Related]
13. Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer.
Renard-Penna R; Cancel-Tassin G; Comperat E; Roupret M; Mozer P; Cussenot O
World J Urol; 2015 Jul; 33(7):929-36. PubMed ID: 25944677
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value.
Platzek I; Borkowetz A; Toma M; Brauer T; Meissner C; Dietel K; Wirth M; Laniado M
J Comput Assist Tomogr; 2015; 39(5):674-80. PubMed ID: 25938212
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.
Okoro C; George AK; Siddiqui MM; Rais-Bahrami S; Walton-Diaz A; Shakir NA; Rothwax JT; Raskolnikov D; Stamatakis L; Su D; Turkbey B; Choyke PL; Merino MJ; Parnes HL; Wood BJ; Pinto PA
J Endourol; 2015 Oct; 29(10):1115-21. PubMed ID: 25897467
[TBL] [Abstract][Full Text] [Related]
16. Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer.
Aydın H; Kızılgöz V; Tekin BO
Kaohsiung J Med Sci; 2015 Apr; 31(4):167-78. PubMed ID: 25835272
[TBL] [Abstract][Full Text] [Related]
17. Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China.
Zhang Q; Wang W; Yang R; Zhang G; Zhang B; Li W; Huang H; Guo H
Int Urol Nephrol; 2015 May; 47(5):727-33. PubMed ID: 25820744
[TBL] [Abstract][Full Text] [Related]
18. False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance.
Quon JS; Moosavi B; Khanna M; Flood TA; Lim CS; Schieda N
Insights Imaging; 2015 Aug; 6(4):449-63. PubMed ID: 26002487
[TBL] [Abstract][Full Text] [Related]
19. Optimal cut-off value of perfusion parameters for diagnosing prostate cancer and for assessing aggressiveness associated with Gleason score.
Cho E; Chung DJ; Yeo DM; Sohn D; Son Y; Kim T; Hahn ST
Clin Imaging; 2015; 39(5):834-40. PubMed ID: 26001659
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer.
Kittel JA; Reddy CA; Smith KL; Stephans KL; Tendulkar RD; Ulchaker J; Angermeier K; Campbell S; Stephenson A; Klein EA; Wilkinson DA; Ciezki JP
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):884-93. PubMed ID: 25962627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
